RD Goals and Pipelines

Ocular diseases can be troublesome and even devastating as vision impairment in any form or stage could immediately cripple patients’ ability to perform activities at work and of daily living; and as the diseases progress over time, negative impacts to their independence, finance as well as the quality of life (to their families too) will become worse.

A dedicated team of experts in TheratOcular Biotek, based on their years of successful experience in bringing small molecule new drug compounds from bench to bedside (POC), are intending to tackle some of the most difficult clinical challenges like nAMD and POAG with technical novelty and creative regulatory strategies. Other disease conditions like dry eye, inflammation, infection or even lens issues like presbyopia and myopia are also in our RD of interest.

Schematic Diagram of RD Pipeline: